Y-mAbs Therapeutics, Inc. Annual Return On Assets in % from 2019 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2019 to 2024.
  • Y-mAbs Therapeutics, Inc. Return On Assets for the quarter ending December 31, 2024 was -23.4 %, a 43.5% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Return On Assets for 2024 was -23.4 %, a 43.5% decline from 2023.
  • Y-mAbs Therapeutics, Inc. annual Return On Assets for 2023 was -16.3 %, a 72.7% increase from 2022.
  • Y-mAbs Therapeutics, Inc. annual Return On Assets for 2022 was -59.6 %, a 166% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -23.4 -7.08 -43.5% Jan 1, 2024 Dec 31, 2024
2023 -16.3 +43.3 +72.7% Jan 1, 2023 Dec 31, 2023
2022 -59.6 -37.2 -166% Jan 1, 2022 Dec 31, 2022
2021 -22.4 +52.6 +70.1% Jan 1, 2021 Dec 31, 2021
2020 -75 -19.7 -35.6% Jan 1, 2020 Dec 31, 2020
2019 -55.3 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.